Aviceda Therapeutics
Latest round
- Series C
Last raised
- Dec 2024
Total raised
- $75M
Investors
- 12
About Aviceda Therapeutics
Founded in 2018 and based in Massachusetts, US, Aviceda Therapeutics Inc. is a biotechnology company developing glyco-immuno therapeutics for inflammatory diseases. The firm was co-founded by Christopher Scott (Scientific Co-Founder), Mohamed Genead, Derek Kunimoto ( Chief Strategy Officer), and Michael Tolentino (CIO). Aviceda Therapeutics specializes in immunomodulatory therapies that harness the body's immune responses to treat inflammation-related diseases. Their core products are highly selective ligands that target specific immune cells to enhance therapeutic precision. Aimed at conditions linked to chronic inflammation, these therapies promote a balanced immune response. Aviceda primarily serves healthcare providers and patients with autoimmune disorders and inflammation-driven diseases, focusing on partnerships with hospitals, specialty clinics, and research institutions in North America and select European countries.
Who invested in Aviceda Therapeutics
12 investors across 1 round
See all investors in Aviceda Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Dec 17, 2024
Amount
$75M
Investors
Questions about Aviceda Therapeutics
Who invested in Aviceda Therapeutics?
Aviceda Therapeutics has 12 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aviceda Therapeutics raised?
Aviceda Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aviceda Therapeutics last raise money?
Aviceda Therapeutics's most recent round on record is a Series C, in Dec 2024.
What does Aviceda Therapeutics do?
Founded in 2018 and based in Massachusetts, US, Aviceda Therapeutics Inc.
Where is Aviceda Therapeutics headquartered?
Aviceda Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Aviceda Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aviceda Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Aviceda Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.